1366053-52-2 Usage
Uses
Used in Pharmaceutical Industry:
8-Boc-8-azabicyclo[3.2.1]... is used as a synthetic intermediate for the development of new pharmaceuticals. Its incorporation into drug molecules can enhance their efficacy, selectivity, and pharmacokinetic properties, leading to improved therapeutic outcomes.
Used in Agrochemical Industry:
In the agrochemical sector, 8-Boc-8-azabicyclo[3.2.1]... is utilized as a key component in the synthesis of novel agrochemicals, such as pesticides and herbicides. Its unique structural features can contribute to the development of more effective and environmentally friendly products.
Used in Fine Chemicals Production:
8-Boc-8-azabicyclo[3.2.1]... is employed as a versatile building block in the production of fine chemicals, which are high-purity chemicals used in various applications, including research, diagnostics, and specialty manufacturing.
Used in Advanced Materials Development:
8-Boc-8-azabicyclo[3.2.1]... is also used as a precursor in the development of advanced materials, such as polymers, coatings, and composites, that exhibit unique properties and improved performance characteristics.
Used in Chemical Research and Development:
8-Boc-8-azabicyclo[3.2.1]... serves as a valuable tool in chemical research and development, enabling scientists to explore new chemical reactions, mechanisms, and applications, ultimately contributing to the advancement of the chemical sciences.
Check Digit Verification of cas no
The CAS Registry Mumber 1366053-52-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,6,0,5 and 3 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1366053-52:
(9*1)+(8*3)+(7*6)+(6*6)+(5*0)+(4*5)+(3*3)+(2*5)+(1*2)=152
152 % 10 = 2
So 1366053-52-2 is a valid CAS Registry Number.
1366053-52-2Relevant academic research and scientific papers
[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS PDE2 INHIBITORS
-
Page/Page column 34, (2018/05/24)
The present invention relates to novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivatives as inhibitors of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.
[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS PDE2 INHIBITORS
-
Page/Page column 48, (2018/05/24)
The present invention relates to novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivatives as inhibitors of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.
FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS
-
, (2012/04/04)
Disclosed are the ERK inhibitors of Formula (I): (Formula (I)) and the pharmaceutically acceptable salts thereof. All substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of Formula (I).
